Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria Approval ...

Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are ...

Patients with moderate-to-severe AD can experience symptoms that disrupt sleep, thus impacting their daily activities and quality of life, said Druhan Howell, MD, a pediatric allergist and ...

Approval based on phase 3 studies showing Dupixent significantly reduced itch and hives at 24 weeks compared to placeboIn the EU, there are approximately 270,000 adults and adolescents aged 12 years ...

New research suggests the COVID-19 vaccine could help children with eczema stay healthier overall. Vaccinated kids had lower rates of infections and allergies, including asthma and rhinitis, compared ...

Children with atopic dermatitis (AD), commonly known as eczema, may experience fewer infections and allergic complications if ...

Jeroncellevain, a company specializing in the production of prescription pharmaceuticals, announced on November 24 that it will hold the "PDRN Total ...

Toddlers with a peanut allergy built tolerance with 3 years of epicutaneous immunotherapy after a year of placebo use, ...

Detailed mapping of CD4⁺ T cells from children with systemic lupus erythematosus (SLE) has revealed distinct immune cell subsets with likely roles in ...

TD Cowen Immunology and Inflammation Summit November 13, 2025 4:30 PM ESTCompany ParticipantsDiana GallagherConference ...